相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series
Ramak Roohipoor et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2011)
Efficacy of Intravitreal Bevacizumab for Stage 3+Retinopathy of Prematurity.
Helen A. Mintz-Hittner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels
Joo Yong Lee et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2010)
Antivascular endothelial growth factor for retinopathy of prematurity
Helen A. Mintz-Hittner et al.
CURRENT OPINION IN PEDIATRICS (2009)
Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study
S. Kusaka et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control
Clare Gilbert
EARLY HUMAN DEVELOPMENT (2008)
Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity
Shigeru Honda et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2008)
An epidemiological analysis of retinopathy of prematurity over 10 years
Carmen Giannantonio et al.
JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS (2008)
Antiangiogenic therapy with intravitreal bevacizumab for retinopathy of prematurity
Hugo Quiroz-Mercado et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Intravitreal injection of bevacizumab (Avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II
Helen A. Mintz-Hittner et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2008)
Survival of extremely premature babies in a geographically defined population: prospective cohort study of 1994-9 compared with 2000-5
David J. Field et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Combination of laser photocoagulation and intravitreal bevacizumab (Avastin®) for aggressive zone I retinopathy of prematurity
Eun Jee Chung et al.
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2007)
Zone I retinopathy of prematurity - Clinical characteristics and treatment outcomes
Andres Kychenthal et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Retinopathy of prematurity: Two distinct mechanisms that underlie zone 1 and zone 2 disease
John T. Flynn et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Outcome of zone 1 retinopathy of prematurity
M O'Keefe et al.
ACTA OPHTHALMOLOGICA SCANDINAVICA (2003)